|
|
|||
|
|||
|
|
|||
|
milk allergies babies |
|||
|
|
|||
|
|||
 
|
|||
|
|
|||
|
milk allergies babies DESCRIPTION Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide milk allergies babies. The molecular weight of zafirlukast is 575.7 and the structural formula is:
Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water milk allergies babies. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone milk allergies babies. ACCOLATE is supplied as 10 and 20 mg tablets for oral administration milk allergies babies. Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide milk allergies babies.
In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans milk allergies babies. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs milk allergies babies. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness milk allergies babies. In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges milk allergies babies. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma milk allergies babies. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma milk allergies babies. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge milk allergies babies. Clinical Pharmacokinetics and Bioavailability: Distribution Metabolism Excretion In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma milk allergies babies. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma milk allergies babies. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg milk allergies babies. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data milk allergies babies. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% milk allergies babies. The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below milk allergies babies. Mean (% Coefficient of Variation) pharmacokinetic
Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed milk allergies babies. Elderly: The apparent oral clearance of zafirlukast decreases with age milk allergies babies. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients milk allergies babies. Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained: Parameter Children age
Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults milk allergies babies. Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects milk allergies babies. Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects milk allergies babies. Drug-Drug Interactions
|
|||
 
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| mmilk allergies babies miilk allergies babies millk allergies babies milkk allergies babies milk allergies babies milk aallergies babies milk alllergies babies milk alllergies babies milk alleergies babies milk allerrgies babies milk allerggies babies milk allergiies babies milk allergiees babies milk allergiess babies milk allergies babies milk allergies bbabies milk allergies baabies milk allergies babbies milk allergies babiies milk allergies babiees milk allergies babiess ilk allergies babies mlk allergies babies mik allergies babies mil allergies babies milkallergies babies milk llergies babies milk alergies babies milk alergies babies milk allrgies babies milk allegies babies milk alleries babies milk allerges babies milk allergis babies milk allergie babies milk allergiesbabies milk allergies abies milk allergies bbies milk allergies baies milk allergies babes milk allergies babis milk allergies babie m ilk allergies babies mi lk allergies babies mil k allergies babies milk allergies babies milk allergies babies milk a llergies babies milk al lergies babies milk all ergies babies milk alle rgies babies milk aller gies babies milk allerg ies babies milk allergi es babies milk allergie s babies milk allergies babies milk allergies babies milk allergies b abies milk allergies ba bies milk allergies bab ies milk allergies babi es milk allergies babie s milk allergies babies imlk allergies babies mlik allergies babies mikl allergies babies mil kallergies babies milka llergies babies milk lalergies babies milk allergies babies milk alelrgies babies milk allregies babies milk allegries babies milk alleriges babies milk allergeis babies milk allergise babies milk allergie sbabies milk allergiesb abies milk allergies abbies milk allergies bbaies milk allergies baibes milk allergies babeis milk allergies babise amilk allergies babies themilk allergies babies milk allergies babies | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |
